These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 25733348

  • 1. Oxidative stress and mechanisms of ochronosis in alkaptonuria.
    Braconi D, Millucci L, Bernardini G, Santucci A.
    Free Radic Biol Med; 2015 Nov; 88(Pt A):70-80. PubMed ID: 25733348
    [Abstract] [Full Text] [Related]

  • 2. Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis.
    Braconi D, Bianchini C, Bernardini G, Laschi M, Millucci L, Spreafico A, Santucci A.
    J Inherit Metab Dis; 2011 Dec; 34(6):1163-76. PubMed ID: 21874298
    [Abstract] [Full Text] [Related]

  • 3. Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria.
    Ranganath LR, Milan AM, Hughes AT, Khedr M, Davison AS, Shweihdi E, Norman BP, Hughes JH, Bygott H, Luangrath E, Fitzgerald R, Psarelli EE, van Kan C, Laan D, Olsson B, Rudebeck M, Mankowitz L, Sireau N, Arnoux JB, Le Quan Sang KH, Jarvis JC, Genovese F, Braconi D, Santucci A, Zatkova A, Glasova H, Stančík R, Imrich R, Rhodes NP, Gallagher JA.
    J Inherit Metab Dis; 2020 Jul; 43(4):737-747. PubMed ID: 31609457
    [Abstract] [Full Text] [Related]

  • 4. Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
    Galderisi S, Milella MS, Rossi M, Cicaloni V, Rossi R, Giustarini D, Spiga O, Tinti L, Salvini L, Tinti C, Braconi D, Millucci L, Lupetti P, Prischi F, Bernardini G, Santucci A.
    Arch Biochem Biophys; 2022 Mar 15; 717():109137. PubMed ID: 35090868
    [Abstract] [Full Text] [Related]

  • 5. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
    Preston AJ, Keenan CM, Sutherland H, Wilson PJ, Wlodarski B, Taylor AM, Williams DP, Ranganath LR, Gallagher JA, Jarvis JC.
    Ann Rheum Dis; 2014 Jan 15; 73(1):284-9. PubMed ID: 23511227
    [Abstract] [Full Text] [Related]

  • 6. Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins.
    Braconi D, Millucci L, Bernini A, Spiga O, Lupetti P, Marzocchi B, Niccolai N, Bernardini G, Santucci A.
    Biochim Biophys Acta Gen Subj; 2017 Feb 15; 1861(2):135-146. PubMed ID: 27865997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alkaptonuria: a very rare metabolic disorder.
    Aquaron R.
    Indian J Biochem Biophys; 2013 Oct 15; 50(5):339-44. PubMed ID: 24772955
    [Abstract] [Full Text] [Related]

  • 9. Development of an in vitro model to investigate joint ochronosis in alkaptonuria.
    Tinti L, Taylor AM, Santucci A, Wlodarski B, Wilson PJ, Jarvis JC, Fraser WD, Davidson JS, Ranganath LR, Gallagher JA.
    Rheumatology (Oxford); 2011 Feb 15; 50(2):271-7. PubMed ID: 20952450
    [Abstract] [Full Text] [Related]

  • 10. A novel ex vivo organotypic culture model of alkaptonuria-ochronosis.
    Tinti L, Spreafico A, Chellini F, Galeazzi M, Santucci A.
    Clin Exp Rheumatol; 2011 Feb 15; 29(4):693-6. PubMed ID: 21813063
    [Abstract] [Full Text] [Related]

  • 11. Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review.
    Ranganath LR, Norman BP, Gallagher JA.
    J Inherit Metab Dis; 2019 Sep 15; 42(5):776-792. PubMed ID: 31282009
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis.
    Braconi D, Laschi M, Amato L, Bernardini G, Millucci L, Marcolongo R, Cavallo G, Spreafico A, Santucci A.
    Rheumatology (Oxford); 2010 Oct 15; 49(10):1975-83. PubMed ID: 20601653
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.
    Tinti L, Spreafico A, Braconi D, Millucci L, Bernardini G, Chellini F, Cavallo G, Selvi E, Galeazzi M, Marcolongo R, Gallagher JA, Santucci A.
    J Cell Physiol; 2010 Oct 15; 225(1):84-91. PubMed ID: 20648626
    [Abstract] [Full Text] [Related]

  • 14. Homogentisic acid affects human osteoblastic functionality by oxidative stress and alteration of the Wnt/β-catenin signaling pathway.
    Schiavone ML, Millucci L, Bernardini G, Giustarini D, Rossi R, Marzocchi B, Santucci A.
    J Cell Physiol; 2020 Oct 15; 235(10):6808-6816. PubMed ID: 31989660
    [Abstract] [Full Text] [Related]

  • 15. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
    Bernini A, Petricci E, Atrei A, Baratto MC, Manetti F, Santucci A.
    Sci Rep; 2021 Nov 19; 11(1):22562. PubMed ID: 34799606
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tyrosinase, could it be a missing link in ochronosis in alkaptonuria?
    Taylor AM, Kammath V, Bleakley A.
    Med Hypotheses; 2016 Jun 19; 91():77-80. PubMed ID: 27142149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.